Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net income	$ 2,216,562	$ 16,595,920
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(48,539)	136,991
Other-than-temporary impairments	0	650,956
Realized investment gains, net	(4,645,699)	(7,598,048)
Change in fair value of equity securities	(6,208,148)	(18,611,248)
Unrealized trading (gains) losses included in income	973	0
Realized trading (gains) losses included in income	(3,894)	132,518
Amortization of cost of insurance acquired	744,850	775,906
Depreciation and depletion	1,697,285	3,141,801
Stock-based compensation	325,668	353,887
Charges for mortality and administration of universal life and annuity products	(6,355,601)	(5,211,485)
Interest credited to account balances	4,012,179	4,088,309
Change in accrued investment income	338,140	440,099
Change in reinsurance receivables	541,295	374,515
Change in policy liabilities and accruals	(2,285,473)	(4,331,160)
Change in income taxes receivable (payable)	(45,165)	592,995
Change in other assets and liabilities, net	(3,527,819)	1,988,577
Net cash used in operating activities	(13,243,386)	(6,479,467)
Proceeds from investments sold and matured:
Fixed maturities available for sale	23,924,989	14,390,181
Equity securities	18,281,727	14,385,393
Trading securities	(579)	0
Mortgage loans	707,274	5,283,749
Real estate	11,983,353	11,181,547
Notes receivable	5,305,162	20,261,459
Policy loans	1,256,793	1,635,686
Short-term investments	18,500,000	0
Total proceeds from investments sold and matured	79,958,719	67,138,015
Cost of investments acquired:
Fixed maturities available for sale	(9,048,928)	(14,634,233)
Equity securities	(15,362,440)	(2,092,304)
Trading securities	15,719	(132,518)
Mortgage loans	(13,213,037)	(4,367,644)
Real estate	(2,995,519)	(1,958,982)
Notes receivable	(3,500,000)	(16,031,605)
Policy loans	(1,043,441)	(1,235,340)
Short-term investments	(7,890,228)	(10,403,628)
Total cost of investments acquired	(53,037,874)	(50,856,254)
Net cash provided by investing activities	26,920,845	16,281,761
Cash flows from financing activities:
Policyholder contract deposits	4,408,039	4,669,825
Policyholder contract withdrawals	(4,343,401)	(4,389,622)
Purchase of treasury stock	(3,313,154)	(909,368)
Non controlling contributions/(distributions) of consolidated subsidiary	(190,818)	(535,662)
Net cash used in financing activities	(3,439,334)	(1,164,827)
Net increase (decrease) in cash and cash equivalents	10,238,125	8,637,467
Cash and cash equivalents at beginning of year	28,787,629	20,150,162
Cash and cash equivalents at end of year	$ 39,025,754	$ 28,787,629